30 Sep 2025
Clinical drug testing plays a vital role in supporting safe and effective care for patients undergoing medication-assisted treatment (MAT) for substance use disorder (SUD), such as opioid use disorder (OUD). As part of Labcorp’s commitment to improve patient and public health outcomes, we hosted a series of webinars focused on clinical drug testing in MAT.
What will I learn about MAT in part one of this webinar?
Our toxicology experts, including an addiction medicine provider, cover topics including:
- Evidence-based best practices, toxicology testing and MAT in supporting recovery from SUD, including OUD
- How drug testing improves compliance
- Advanced specimen validity
- Evolving drug trends and adapting treatment approaches in addiction recovery settings
Speakers:
Hemamalini Ketha, PhD, NRCC, SC (ASCP), FAAC
Discipline Director, Clinical Toxicology, Labcorp
Karla J. Walker, PharmD, DABCC, FAACC
Discipline Director, Clinical Toxicology, Labcorp
Dr. Tania Hernandez
Dr. Hernandez is a board-certified physician in family medicine and addiction medicine. Dr. Hernandez has led the development of comprehensive addiction treatment programs across diverse clinical settings, including community health centers and correctional facilities treating high-risk and underserved populations. She currently directs the MOUD program at the Monroe Correctional Complex in Washington State, integrating primary care, behavioral health and harm reduction into recovery pathways.